Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 4(51), p. 1512-1514, 2007
DOI: 10.1128/aac.00959-06
Links
- ORCID
- American Society for Microbiology | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [hdl.handle.net]
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci
Journal article published in 2007 by
Seong Geun Hong 
,
Ellen Smith Moland,
Paul A. Wickman,
Jennifer A. Black,
Ashfaque Hossain,
Nancy D. Hanson,
Kenneth S. Thomson
,
Ellen Smith Moland,
Paul A. Wickman,
Jennifer A. Black,
Ashfaque Hossain,
Nancy D. Hanson,
Kenneth S. Thomson
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
ABSTRACT DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.